1. Service d’Epidemiologie et Santé Publique, Institut Pasteur de Lille; Inserm, U744; Univ Lille Nord de France; Lille Cedex 59019, France.
2. Department of Preventative Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid/IdiPaz, CIBER of Epidemiology and Public Health, Madrid, Spain.
3. Université Paris Diderot, Paris, F-75018, France; INSERM, CIE 801, Paris, F-75018, France; INSERM, UMR-S 738, Paris, F-75018, France; APHP, Hôpital Bichat-Claude Bernard, Département d’Epidémiologie, Biostatistique et Recherche Clinique, Paris, F-75018, France.
4. Departments of Epidemiology and Medicine and Welch Center for Prevention, Epidemiology, and Clinical Research, John Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
5. Department of Cardiovascular Epidemiology and Population Genetics, National Center for Cardiovascular Research (CNIC), Madrid, Spain.
6. Department of Internal Medicine, Ageing and Clinical Nephrology, University of Bologna, Bologna, Italy.
7. Department of Public Health, University of Gent, Gent, Belgium.
8. Wales Heart Research Institute, Cardiff University, Heath Park, Cardiff, UK.
9. Medical Department, AstraZeneca Farmacéutica Spain, SA, Madrid, Spain.
10. School of Health and Caring Sciences, Linnaeus University, Kalmar 391 82, Sweden.
11. Medical Department, AstraZeneca Europe, Zaventem, Belgium.
12. INSERM U698, Assistance Publique-Hôpitaux de Paris and Université Paris 7, Paris, France.